Vestibular Function Using Mitochondrial Antioxidant Therapy
Status:
Withdrawn
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
To determine if supplementation with known mitochondrial antioxidants (alpha lipoic acid
(ALA) and CoQ-10) will stabilize or improve vestibular function in older adults.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio